LAG3 and ovarian carcinoma: found that when PD-1 were individually blocked in metastatic ovarian cancer cells, other immune checkpoints (LAG-3, CLTA-4) were upregulated accordingly (115).Because of this negative feedback mechanism of immune checkpoints, some researchers believe that research can be explored in the direction of multi-target blockade (116).